We are live on ! Find out more
MBIO icon

Mustang Bio

30 hedge funds and large institutions have $827K invested in Mustang Bio in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more capital invested

Capital invested by funds: $207K → $827K (+$619K)

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

20% more funds holding

Funds holding: 2530 (+5)

0.14% more ownership

Funds ownership: 0.05%0.19% (+0.14%)

Holders
30
Holders Change
+5
Holders Change %
+20%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
6
Reduced
3
Closed
6
Calls
Puts
Net Calls
Net Calls Change

MBIO Hedge Fund Activity: Q4 2024 in Review

30 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2024, worth a combined $827K — up 299% from $207K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MBIO positions and 6 closed out — a net gain of 5 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $796K. The largest seller was Citadel Advisors, exiting entirely with an estimated $26.5K sold.

  • 30 institutional investors held Mustang Bio (MBIO) as of Q4 2024, up from 25 in Q3 2024.
  • Funds reported $827K of Mustang Bio stock for Q4 2024, up 299% quarter-over-quarter.
  • 11 funds opened new Mustang Bio positions in Q4 2024 and 6 closed out, a net change of +5 holders.
  • The largest Mustang Bio buyer in Q4 2024 was Armistice Capital, an estimated $796K added.
  • The largest Mustang Bio seller in Q4 2024 was Citadel Advisors, an estimated $26.5K sold.

Based on aggregated 13F filings for Q4 2024.